A new paradigm for diabetes and obesity: The hepatic insulin sensitizing substance (HISS) hypothesis

Journal of Pharmacological Sciences

Volumn 95, Issue 1, 2004, Pages 9-17

  Lautt, W Wayne ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Diabetes; Feeding; Hypertension; Insulin resistance; Obesity

Indexed keywords

GLUCOSE; HEPATIC INSULIN SENSITIZING SUBSTANCE; INSULIN; MUSCARINIC RECEPTOR; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; SUCROSE; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTONOMIC DENERVATION; CHOLINERGIC SYSTEM; DIABETES MELLITUS; DRUG MECHANISM; FEEDING; FETAL ALCOHOL SYNDROME; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; HEPATIC INSULIN SENSITIZING SUBSTANCE DEPENDENT INSULIN RESISTANCE; HYPERGLYCEMIA; INSULIN RESISTANCE; LIVER DISEASE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARASYMPATHETIC NERVE; PHARMACODYNAMICS; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; STRESS;

EID: 3042750029     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.95.9     Document Type: Review

References (43)

1. Xie H, Tsybenko VA, Johnson MV, Lautt WW. Insulin resistance of glucose response produced by hepatic denervations. Can J Physiol Pharmacol. 1993;71:175-178.
2. Xie H, Lautt WW. Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am J Physiol. 1996;271:E587-E592.
3. Lautt WW, Macedo MP, Sadri P, Takayama S, Ramos FD, Legare DJ. Hepatic parasympathetic nerve-dependent control of peripheral insulin sensitivity is determined by feeding and fasting: dynamic control of HISS-dependent insulin action. Am J Physiol Gastrointest Liver Physiol. 2001;281:G29-G36.
4. Latour MG, Lautt WW. Insulin sensitivity regulated by feeding in the conscious unrestrained rat. Can J Physiol Pharmacol. 2002;80:8-12.
5. Xie H, Lautt WW. Induction of insulin resistance by cholinergic blockade with atropine in the cat. J Auton Pharmacol. 1995;15:361-369.
6. Moore MC, Satake S, Baranowski B, Hsieh P-S, Neal DW, Cherrington AD. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab. 2002;282:E286-E296.
7. Latour MG, Chan CC. A rapid insulin sensitivity test (RIST) in anesthetized mice. Diabetes. 2002;51 Suppl 2:A422.
8. Lautt WW. State of the Art 1997: Hepatic parasympathetic nerves and glucose metabolism. In: Haussinger D, Jungermann K, editors. Liver and nervous system. Falk Symposium No. 103. UK: Kluwer Academic Publishers; 1998. p 1-14.
9. Lautt WW. Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: methods to quantitate mechanisms of insulin resistance. Med Res Rev. 2003;23:1-14.
10. Xie H, Lautt WW. Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am J Physiol. 1996;270:E858-E863.
11. Reid MAG, Latour MG, Legare DJ, Rong N, Lautt WW. Comparison of the rapid insulin sensitivity test (RIST), the insulin tolerance test (ITT), and the hyperinsulinemic euglycemic clamp (HIEC) to measure insulin action in rats. Can J Physiol Pharmacol. 2002;80:811-818.
12. Xie H, Zhu L, Zhang YL, Legare DJ, Lautt WW. Insulin sensitivity tested with a modified euglycemic technique in cats and rats. J Pharmacol Toxicol Meth. 1996;35:77-82.
13. Lautt WW, Wang X, Sadri P, Legare DJ, Macedo MP. Rapid insulin sensitivity test (RIST). Can J Physiol Pharmacol. 1998;76:1080-1086.
14. Ribeiro RT, Duarte-Ramos F, Macedo MP. The fatty Zucker fa/fa rat show a dysfunction of the HISS dependent and independent components of insulin action. Proc West Pharmacol Soc. 2001;44:27-28.
15. Ribeiro RT, Duarte-Ramos F, Macedo MP. Effect of the hepatic insulin sensitizing substance (HISS) action in the spontaneously hypertensive rats. Proc West Pharmacol Soc. 2001;44:29-30.
16. Takayama S, Legare DJ, Lautt WW. Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc West Pharmacol Soc. 2000;43:33-34.
17. d'Almeida MS, Reid MAG, Legare DJ, Lautt WW. Inhibition of acetylcholinesterase: a novel approach to improve insulin sensitivity in experimental models of insulin resistance. Can J Diabetes. 2003;27:332.
18. Sadri P, Lautt WW. Insulin resistance caused by hepatic COX inhibition. Diabetes. 2000;49 Suppl 1:A245.
19. Xie H, Lautt WW. Insulin resistance produced by hepatic denervation or muscarinic cholinergic blockade. Proc West Pharmacol Soc. 1994;37:39-40.
20. Sadri P, Legare DJ, Lautt WW. Insulin resistance caused by nitric oxide synthase inhibition. Proc West Pharmacol Soc. 1997;40:19-20.
21. Sadri P, Lautt WW. Blockade of hepatic nitric oxide synthase causes insulin resistance. Am J Physiol. 1999;277:G101-G108.
22. Correia NC, Guarino MP, Raposo J, Macedo MP. Hepatic guanylyl cyclase inhibition induces HISS dependent insulin resistance. Proc West Pharmacol Soc. 2002;45:57-58.
23. Guarino MP, Afonso RA, Raimundo N, Raposo JF, Macedo MP. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action. Am J Physiol Gastrointest Liver Physiol. 2003;284:G588-G594.
24. Porszasz R, Legvari G, Nemeth J, Literati PN, Szolcsanyi J, Szilvassy Z. The sensory nitrergic nature of the hepatic insulin sensitizing substance mechanism in conscious rabbits. Eur J Pharmacol. 2002;443:211-212.
25. Ribeiro RT, Duarte-Ramos F, Macedo MP. The hepatic insulin sensitizing substance (HISS) action is decreased in rats on a high-sucrose diet. Proc West Pharmacol Soc. 2001;44:31-32.
26. d'Almeida MS, Legare DJ, Lautt WW. Decreased hepatic insulin sensitizing substance (HISS) accounts for insulin resistance observed in sucrose fed rats. Can J Diabetes. 2002;2:301.
27. Lautt WW, Xie H. Intraportal acetylcholine reverses insulin resistance caused by chronic bile duct ligation. Proc West Pharmacol Soc. 1998;41:35-36.
28. Minuk GY, Meyers AFA, Legare DJ, Sadri P, Lautt WW. Fetal exposure to alcohol results in adult insulin resistance in the rat. Proc West Pharmacol Soc. 1998;41:39-40.
29. Sadri P, Legare DJ, Takayama S, Lautt WW. Fetal ethanol exposure causes hepatic insulin sensitizing substance-dependent insulin resistance. Can J Diabetes. 2003;27:239-247.
30. Latour MG, Lautt WW. The hepatic vagus nerve in the control of insulin sensitivity in the rat. Auton Neurosci. 2002;95:25-130.
31. Guarino MP, Correia NC, Raposo JF, Macedo MP. Nitric oxide synthase inhibition decreases hepatic insulin sensitizing substance output which is reversed by SIN-1 but not by nitroprusside. Proc West Pharmacol Soc. 2001;44:25-26.
32. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-819.
33. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care. 1997;20:1822-1826.
34. de Vegt F, Dekker JM, Ruhé HG, Stehouwer CDA, Nijpels GBLM, Heine RJ. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia. 1999;42:926-931.
35. DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 1999;354:617-621.
36. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39:1577-1583.
37. Engelgau MM, Narayan KMV, Herman WH. Screening for type 2 diabetes. Diabetes Care. 2000;23:1563-1580.
38. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G. Risk of diabetes in the new diagnostic category of impaired fasting glucose. Diabetes Care. 1999;22:1490-1493.
39. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycemia confirmed as a risk factor for mortality. Diabetologia. 1999;42:1050-1054.
40. Simon C, Brandenberger G. Ultradian oscillations of insulin secretion in humans. Diabetes. 2002;51 Suppl 1:S258-S261.
41. Simon C, Follenius M, Brandenberger G. Postprandial oscillations of plasma glucose insulin and C-peptide in man. Diabetologia. 1987;30:769-773.
42. Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev. 2001;17:164-174.
43. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature. 2001;414:821-827.